Jon Frampton

71 - 80 out of 96Page size: 10
Sort by: Title

Publications

  1. E-pub ahead of print

    Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction

    Emilie Dasse, Jon Frampton, 2 Dec 2015, In : Blood.

    Research output: Contribution to journal › Article

  2. Published

    Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells

    Fiona Tavner, Jon Frampton, 30 Oct 2006, In : Oncogene. 26, 19, p. 2727-35 9 p.

    Research output: Contribution to journal › Article

  3. Published

    Targeting the transcription factor Myb by small-molecule inhibitors

    Jon Frampton, 1 Mar 2017, In : Experimental Hematology. 47, p. 31-35

    Research output: Contribution to journal › Article

  4. Published

    The Evi-1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity

    Jon Frampton, 1 Sep 2005, In : British Journal of Haematology. 130, p. 902-11 10 p.

    Research output: Contribution to journal › Article

  5. Published

    The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI

    Oscar Berlanga, Jon Frampton, 1 Jun 2002, In : European Journal of Biochemistry. 269, 12, p. 2951-2960 10 p.

    Research output: Contribution to journal › Article

  6. Published

    The TspanC8 subgroup of tetraspanins interacts with a disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression

    Elizabeth Haining, Steve Watson, Jon Frampton, Paloma Garcia & Michael Tomlinson, 16 Nov 2012, In : Journal of Biological Chemistry. 287, 47, p. 39753-39765 13 p.

    Research output: Contribution to journal › Article

  7. Published

    The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis

    Jon Frampton, 1 Jul 2003, In : Immunity. 19, p. 33-45 13 p.

    Research output: Contribution to journal › Article

  8. Published

    The heptapeptide LSARLAF mediates platelet activation through phospholipase Cy 2 independently of glycoprotein 11b-111a

    Andrew Pearce, Steve Watson & Jon Frampton, 15 Feb 2004, In : Biochemical Journal. 378, 1, p. 193-199 7 p.

    Research output: Contribution to journal › Article

  9. Published

    The homeodomain protein PRH influences the differentiation of haematopoietic cells

    Padma-Sheela Jayaraman, Jon Frampton, Dec 2000, In : Leukaemia Research. 24, 12, p. 1023-31 9 p.

    Research output: Contribution to journal › Article

  10. Published

    The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters

    Jon Frampton & 1 others, , Jan 2015, In : Cell Research. 25, 1, p. 80-92 13 p.

    Research output: Contribution to journal › Article

Previous 1...4 5 6 7 8 9 10 Next